Hamdard labs to conduct clinical trials of immunity booster medicines against coronavirus
Shortpedia
Content TeamImage Credit: shortpedia
Health and wellness firm Hamdard Laboratories on Tuesday said it is planning to conduct clinical trial of its immunity booster medicines to assess their effectiveness against coronavirus. The firm has submitted the proposal for required permission from the concerned authorities and the clinical trial will be conducted at Hamdard Institute of Medical Sciences and Research, New Delhi, the company said.